Delivery Order SPE2DB22D2206-SPE2DB25FEW95
Award Date
12/30/24
Potential Completion Date
1/22/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.87 firm fixed-price delivery order contract is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of January 27, 2025.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The $23,824.28 firm-fixed-price delivery order has an ultimate completion date of August 13, 2024. This award is under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,323.84, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tecvayli 153 mg/1.7 ml vial. The contract, valued at $23,824.28, is a delivery order with a firm fixed price. The award has an ultimate completion date of August 6, 2024. AmerisourceBergen, through its corporate office division, will deliver the pharmaceutical product to support military treatment facilities and other federal...
The U.S. Defense Logistics Agency (DLA) awarded a $23,824.28 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through July 2024.
Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense and Veterans Affairs healthcare systems. The company...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. The contract has a potential value of $23,824.28 and a completion date of March 20, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
This federal contract award, valued at $6,161.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract is a firm-fixed-price delivery order with a period of performance through December 31, 2024.
Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award, valued at $59,560.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which is a Delivery Order, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. The contract has a firm fixed price and a completion date of September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery...
This federal contract award is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML to the Defense Logistics Agency (DLA). The $23,824.28 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 16, 2024. The contract has an ultimate completion date of May 7, 2024 and is not set aside.
Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...